| Name | 7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1-[4-(trideuteriomethoxy)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide |
|---|---|
| Synonyms | Apixaban-d3 |
| Description | Apixaban-d3 (BMS-562247-01-d3)is the deuterium labeledApixaban(HY-50667)[1]. Apixaban (BMS-562247-01) is a highly selective, reversible and orally active inhibitor of Factor Xa with Ki of 0.08 nM and 0.17 nM in human and rabbit, respectively[2]. Apixaban is in development for the prevention and treatment of various thromboembolic diseases[3]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C25H22D3N5O4 |
|---|---|
| Molecular Weight | 462.52 |
| Exact Mass | 462.20900 |
| PSA | 111.75000 |
| LogP | 3.71380 |